SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.
Trial details
- Registry ID
- NCT03131154
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as Vehicle of Reproxlap
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.NCT03131154 | ALDX | Phase 3 | Completed | 2019-04-19Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |